Invo Bioscience Inc (INVO)

Überblick Nachrichten Preisverlauf Financials Warum fällt INVO? Forum Prognose Aktiensplit

Finanzdaten der Invo Bioscience Inc-Aktie (INVO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	14.08% 1.5763	1.3818	0.9749	0.3159	0.348
Cost Of Revenue	0.8502	-	-	-	0.0726
Gross Profit	0.7261	-	-	-	0.2755
Operating Expenses	42.14% 1.6724	2.8902	1.8612	2.3819	2.5819
Interest Income/Expense	0.41% 0.1813	0.182	0.3521	0.1752	0.2166
Benefits Costs and Expenses	5.44% 3.171	3.3535	2.2214	2.5535	2.8989
Costs And Expenses	24.78% 2.5227	3.3535	2.2214	2.5535	2.8989
Depreciation and Amortization	60.28% 0.227	0.1416	0.0205	0.0197	0.0191
Operating Income/Loss	37.26% -0.9464	-1.5085	-0.8863	-2.066	-2.3064
Nonoperating Income/Loss	39.94% -0.6483	-0.4633	-0.3603	-0.1717	-0.2445
Income/Loss Before Equity Method Investments	17.95% -1.5948	-1.9436	-1.2384	-2.2414	-2.5231
Income/Loss From Equity Method Investments	100.37% 0.000104	-0.0282	-0.00816	0.00379	-0.0277
Income/Loss From Continuing Operations Before Tax	19.12% -1.5947	-1.9717	-1.2466	-2.2376	-2.5509
Income/Loss From Continuing Operations After Tax	20.25% -1.5947	-1.9995	-1.2466	-2.2405	-2.5509
Net Income/Loss	19.97% -1.5965	-1.9948	-1.2484	-2.2405	-2.5509
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	634.19% 3.8019	0.5178	1.7769	0.7323	12.45
Diluted Average Shares	634.19% 3.8019	0.5178	1.7769	0.7323	12.45
Basic Earnings Per Share	166.67% -0.42	0.63	-0.70	-3.06	-0.20
Diluted Earnings Per Share	166.67% -0.42	0.63	-0.70	-3.06	-0.20
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

STE

$207.49

1.54%

ZBH

$107.12

1.24%

PHG

$25.11

0.32%

DXCM

$80.04

5.57%

GEHC

$78.91

1.91%

$74.81

1.19%